Triacetyloleandomycin: its use in the treatment of acne and pyodermas caused by resistant Staphylococcus aureus.
D000152:Acne Vulgaris / Q000628:therapy*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D055624:Methicillin-Resistant Staphylococcus aureus; D008837:Micrococcus / Q000472:pathogenicity* / Q000628:therapy*; D011711:Pyoderma / Q000628:therapy*; D013203:Staphylococcal Infections; D013211:Staphylococcus aureus; D014217:Troleandomycin
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D014217:Troleandomycin
ACNE/therapy; ANTIBIOTICS/therapeutic use; MICROCOCCAL INFECTIONS/therapy; PYODERMA/therapy